Obagi Medical Products, Inc. (OMPI)

Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets skincare products in the United States and internationally. The company develops and commercializes prescription-based, topical skin health systems that enable physicians to treat a range of skin conditions, including pre-mature aging, photo-damage, hyper-pigmentation, and acne, as well as soft tissue deficits, such as fine lines and wrinkles. It offers Obagi Nu-Derm System, a prescription-based, topical skin health system on the market that has been shown to enhance the skin’s overall health by correcting photo-damage at the cellular level; Obagi-C Rx System, a combination of prescription and OT...



Contact Information:
Business Address: | 3760 Kilroy Airport Way, Suite 500, Long Beach, CA 90806, United States |
Mailing Address: | - |
Phone: | 562-628-1007 |
Fax: | 562-628-1008 |
Website: | http//www.obagi.com |
Company Details:
Symbol: | OMPI |
SIC: | 2834 |
State location: | CA |
Sector: | - |
State of Inc: | DE |
Employees: | 197 |
Type: | - |
Key executives:
Name | Age | Position |
---|---|---|
Curtis A. Cluff | 56 | Exec. VP of Operations, Exec. VP of Corp. Devel. and Sec. |
David Goldstein | 61 | Exec. VP of Global Sales and Field Marketing |
Judith C. Hattendorf | 79 | Sr. VP of Product Devel. |
Stephen A. Garcia | 63 | Chief Financial Officer and Principal Accounting Officer |
Steven R. Carlson | 65 | Chief Exec. Officer, Pres |